R

ReNeuron Group PLC
LSE:RENE

Watchlist Manager
ReNeuron Group PLC
LSE:RENE
Watchlist
Price: 3.375 GBX -2.17%
Market Cap: 1.9m GBX

Wall Street
Price Targets

RENE Price Targets Summary
ReNeuron Group PLC

There are no price targets for RENE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ReNeuron Group PLC Competitors:
Price Targets
6855
Ascentage Pharma Group International
100% Upside
CSL
CSL Ltd
42% Upside
AUPH
Aurinia Pharmaceuticals Inc
12% Upside
IVA
Inventiva SA
200% Upside
MDXH
MDxHealth SA
101% Upside
AZT
Arcticzymes Technologies ASA
57% Upside
KURA
Kura Oncology Inc
221% Upside
300142
Walvax Biotechnology Co Ltd
35% Downside

Revenue
Forecast

Revenue Estimate
ReNeuron Group PLC

For the last 8 years the compound annual growth rate for ReNeuron Group PLC's revenue is 43%. The projected CAGR for the next 2 years is 380%.

43%
Past Growth
380%
Estimated Growth
Estimates Accuracy
-62%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ReNeuron Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
ReNeuron Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RENE's stock price target?
Not Available

RENE doesn't have any price targets made by Wall Street professionals.

What is ReNeuron Group PLC's Revenue forecast?
Projected CAGR
380%

For the last 8 years the compound annual growth rate for ReNeuron Group PLC's revenue is 43%. The projected CAGR for the next 2 years is 380%.

Back to Top